NASDAQ · Medical Instruments & Supplies · USD
Medline Inc. (MDLN) Stock Analysis
Medline Inc. (MDLN) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
MDLN Key Statistics
As of Sep 4, 2026Trading
- Open
- $36.20
- Previous Close
- $36.59
- Day's Range
- 36.04–36.99
- 52-Week Range
- 32.49–50.88
- Volume
- 5.24M
Valuation
- Market Cap
- $49.23B
- P/E Ratio
- 45.74
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 23.07
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.64
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 0.80
Financials (FY)
- Revenue (FY)
- $28.43B
- Net Income (FY)
- $1.16B
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 2.31%
- Shares Outstanding
- 877.35M
Dividend and dates
- Earnings Date
- November 4, 2026estimated
- Avg Volume
- 7.82M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
MDLN Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −12.88% |
| 2025 (partial year) | +2.44% |
As of September 4, 2026.
MDLN Valuation vs Medical Instruments & Supplies Median
Median of 55 stocks| Metric | MDLN | Medical Instruments & Supplies median | vs median |
|---|---|---|---|
| P/E | 45.74 | 35.61 | 28% above |
| P/S ratio | 1.64 | 3.17 | 48% below |
| Profit margin | 2.31% | 0.85% | 1.5 pts above |
Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Artisan Sold Medline (MDLN) as Cost Pressures Delayed the Company’s Profit Recovery
YahooMedline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
YahooBTIG Reiterates Buy on Medline, Maintains $55 Price Target
BenzingaReported Earlier, FDA Says Medline Issued Correction For Convenience Kits Containing B. Braun Bupivacaine Hydrochloride Components, Identified As Most Serious Recall Type; B. Braun Reported 35 Serious Injuries, No Deaths
BenzingaMedline Convenience Kits Impacted By Contamination In Recalled Becton Dickinson Products
BenzingaJP Morgan Maintains Overweight on Medline, Lowers Price Target to $46
Benzinga
All 17 articles ↓Show fewer ↑
Wells Fargo Maintains Equal-Weight on Medline, Lowers Price Target to $34
BenzingaTD Cowen Maintains Buy on Medline, Lowers Price Target to $45
BenzingaRBC Capital Maintains Outperform on Medline, Lowers Price Target to $46
BenzingaTruist Securities Maintains Buy on Medline, Lowers Price Target to $47
BenzingaEvercore ISI Group Maintains Outperform on Medline, Lowers Price Target to $39
BenzingaStifel Maintains Buy on Medline, Lowers Price Target to $45
BenzingaMedline Inc. (MDLN) Q2 2026 Earnings Call Transcript
SeekingAlphaMedline (NASDAQ:MDLN) Tumbles as Q2 Earnings Beat Offset by Lowered Full-Year EBITDA Guidance
ChartMillMedline Inc. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlphaMedline Q2 Adj. EPS $0.50 Beats $0.32 Estimate, Sales $7.685B Beat $7.512B Estimate
BenzingaBTIG Reiterates Buy on Medline, Maintains $55 Price Target
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Medical Instruments & Supplies Stocks
Intuitive Surgical, Inc.
$131.38B
BDXBecton, Dickinson and Company
$50.32B
ALCAlcon Inc.
$34.08B
RMDResMed Inc.
$32.94B
WSTWest Pharmaceutical Services, Inc.
$23.93B
HOLXHologic, Inc.
$16.97B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B












